Apogee Therapeutics, Inc.
APGE
Rangering i aksjer
#2365
Apogee Therapeutics, Inc. is a biotechnology firm, operating via its... Apogee Therapeutics, Inc. is a biotechnology firm, operating via its subsidiary, dedicated to advancing biologic treatments for conditions such as atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and a range of other inflammatory and immunological disorders. Its primary focus includes APG777, a subcutaneous (SQ) monoclonal antibody (mAb) engineered for an extended half-life to treat AD, and APG808, a similarly formulated SQ extended half-life mAb targeting COPD. Furthermore, its earlier-stage pipeline features APG990, another SQ extended half-life mAb designed for AD, and APG222, comprising extended half-life subcutaneous antibodies also aimed at AD. Established in 2022, the company maintains its headquarters in Waltham, Massachusetts.
Aksjekurs
$135.07
Sist synkronisert: 2026-09-04
Markedsverdi
$8.36B
Endring (1 dag)
0.00%
Endring (1 år)
137.21%
Land
US
Handel Apogee Therapeutics, Inc. (APGE)
Kategori
Healthcare
Historikk for aksjesplitt for Apogee Therapeutics, Inc. (APGE)
Aksjen Apogee Therapeutics, Inc. (symbol: APGE) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én APGE-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 APGE-aksjer.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én APGE-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 APGE-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
